[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]
A Products and services for Illness Withhold watch over and Prevention advisory panel is assembly Thursday to talk about a necessary, nonetheless rare, autoimmune dysfunction linked to Johnson & Johnson‘s Covid-19 vaccine.
The CDC’s Advisory Committee on Immunization Practices assembly comes a runt bit over a week after the Food and Drug Administration announced a contemporary warning designate for the J&J shot after 100 preliminary stories of Guillain-Barre syndrome were detected in J&J recipients.